|
|
||||||||
Departments of Physiology and Biophysics and Medicine, Case Western Reserve University, Cleveland, Ohio 44106
| |
ABSTRACT |
|---|
|
|
|---|
Glucose transporter isoform-1 (GLUT-1) expression is stimulated in response to stressful conditions. Here we examined the mechanisms mediating the enhanced expression of GLUT-1 by hyperosmolarity. GLUT-1 mRNA, GLUT-1 protein, and glucose transport increased after exposure of Clone 9 cells to 600 mosmol/l (produced by addition of mannitol). The stimulation of glucose transport was biphasic: in the early phase (0-6 h) a ~2.5-fold stimulation of glucose uptake was associated with no change in the content of GLUT-1 mRNA, GLUT-1 protein, or GLUT-1 in the plasma membrane, whereas the ~17-fold stimulation of glucose transport during the late phase (12-24 h) was associated with increases in both GLUT-1 mRNA (~7.5-fold) and GLUT-1 protein content. Cell sorbitol increased after 3 h of exposure to hyperosmolarity. The increase in GLUT-1 mRNA content was associated with an increase in the half-life of the mRNA from 2 to 8 h. A 44-bp region in the proximal GLUT-1 promoter was necessary for basal activity and for the two- to threefold increases in expression by hyperosmolarity. It is concluded that the increase in GLUT-1 mRNA content is mediated by both enhanced transcription and stabilization of GLUT-1 mRNA and is associated with increases in GLUT-1 content and glucose transport activity.
glucose transporter isoform-1; sorbitol; aldose reductase; GLUT-1 messenger ribonucleic acid; GLUT-1 promoter; GLUT-1 messenger ribonucleic acid half-life
| |
INTRODUCTION |
|---|
|
|
|---|
THE ADAPTIVE RESPONSE OF CELLS to stressful conditions is mediated by a variety of specific transcriptional and posttranscriptional mechanisms. GLUT-1, a member of the facilitative glucose transporter family of proteins, is among a subset of genes and gene products that respond to stress (21, 23). GLUT-1-mediated glucose transport is augmented by a variety of stressful stimuli and conditions, including hypoxia, a rise in intracellular calcium concentration, inhibition of oxidative phosphorylation, transformation, and incubation in medium low in glucose or high in pH (15, 34). Detailed study of the glucose transport response to some of the above stimuli demonstrates that the enhancement of glucose transport is biphasic with the early phase being mediated by posttranslational mechanisms and the late phase involving enhancement of GLUT-1 gene expression (2, 27).
The generalized cellular response to hyperosmolar stress has been examined in considerable detail, and the specific pathways and mechanisms underlying this response continue to be under active study. After the acute phase of the response, which is mediated predominantly by changes in the ionic fluxes across the plasma membrane (and hence in the ionic composition of cells), there is a chronic adaptive phase that involves net cellular accumulation of osmolytes and a further adjustment of the internal ionic composition (10, 18). These osmolytes are either accumulated from the external medium after the induction of their specific transporters (e.g., betaine, myo-inositol) or are synthesized within the cells (e.g., sorbitol).
In the present study, we describe and examine the mechanisms underlying the stimulation of GLUT-1-mediated glucose transport after exposure to hyperosmolar stress. Our interest to study this regulation stems from suggestions that GLUT-1 is considered to be a stress-response protein (32, 34). An increase in the content of GLUT-1 in response to prolonged (24 h) exposure to hyperosmolarity has been described in L6 cells (30), but mechanisms underlying the response are not known. We chose Clone 9 cells (a nontransformed rat liver cell line) for investigation because this cell line has been used in other studies focused on hyperosmolarity (16) and because previous results have shown that glucose transport is rate limiting for glucose metabolism in these cells (7, 20). In addition, GLUT-1 appears to be the only isoform of the GLUT family that is expressed in these cells, which serves to simplify the analysis (26). A preliminary report of some of these findings has been presented (14).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials.
Clone 9 cells were obtained from American Type Culture Collection
(Rockville, MD). [
-32P]dCTP (3,000 Ci/mmol) and
3-O-methyl-D-[3H]glucose
(3-[3H]OMG; 3.4 mCi/mmol) were purchased from NEN Life
Science Products (Boston, MA) and Amersham Pharmacia Biotech
(Piscataway, NJ), respectively. Random primed DNA labeling kit and
FuGENE 6 were from Roche Molecular Biochemicals (Indianapolis, IN).
Nitrocellulose paper (BA-S 85) was obtained from Schleicher and Schuell
(Keene, NH). Quickhyb was obtained from Stratagene (La Jolla, CA).
Dulbecco's modified Eagle's medium (DMEM), Hanks' balanced salt
solution, calf serum, horseradish peroxidase-conjugated anti-rabbit
antibody, and streptavidin-agarose bead were obtained from Life
Technologies (Grand Island, NY). Culture dishes were obtained from
Corning (Acton, MA). Qiagen Plasmid Maxi Kit was obtained from Qiagen (Valencia, CA). Dual luciferase reporter assay system, pGL2-Basic plasmid, pRL-TK plasmid, Wizard Plus Minipreps system, and restriction endonucleases were purchased from Promega (Madison, WI).
Sulfo-NHS-SS-biotin was from Pierce (Rockford, IL). Standard chemicals
were obtained from Sigma (St. Louis, MO).
Reporter constructs. The ~6.3 kbp rat GLUT-1 promoter region was deleted serially from its 5'-end to prepare constructs containing different segments of the GLUT-1 promoter, as previously described (3). Some reporter constructs were prepared by PCR amplification of specific regions of the promoter that were then subcloned into pGL2-Basic luciferase reporter vector. In all instances the products were verified by sequencing of both DNA strands.
Cell culture, transfection, and luciferase reporter assays. Clone 9 cells were passed and maintained in DMEM containing 10% calf serum at 37°C with 8% CO2 (20). Cells were employed between passages 29 and 45. The medium was changed to serum-free DMEM for all experiments. Culture media were made hyperosmolar by the addition of various osmolytes, usually mannitol at 300 mosmol/l. Cells (in duplicate or triplicate culture dishes) were cotransfected (at 60% confluence) with 2 µg of pGL2-Basic plasmid constructs containing various segments of the GLUT-1 promoter and expressing the firefly luciferase and 0.2 µg of pRL-TK plasmid (expressing Renilla luciferase) employing FuGENE 6. After 48 h, the media were changed to serum-free isotonic or hypertonic medium, and the incubation continued for an additional 24 h before measurement of luciferase activity. In experiments designed to measure basal GLUT-1 promoter activity, the activity of firefly luciferase was corrected against Renilla luciferase activity. In experiments testing the effect of hyperosmolarity, firefly luciferase activity was normalized against the protein content of control and experimental culture plates, because Renilla luciferase activity increased dramatically in response to hyperosmolarity.
Measurement of 3-[3H]OMG uptake. Culture plates in triplicate were incubated for 60 s in glucose uptake medium, as described (20). The uptake medium consisted of 1.0 ml DMEM containing 5 µCi 3-[3H]OMG and 1 µl of either DMSO alone or DMSO containing cytochalasin B (CB) such that the final concentration of the latter was 50 µM. In cells incubated in hyperosmolar medium, the osmolarity of the uptake medium was adjusted to hyperosmolar levels before use. Cells were harvested in 1 ml of H2O, and the radioactivity was determined by scintillation spectrometry. CB-inhibitable 3-OMG transport was calculated as the difference between the uptake in the absence and presence of CB. Uptakes in control and treated cells were performed in parallel.
Measurement of sorbitol.
Sorbitol was measured by enzymatic assay using sorbitol dehydrogenase
(19). In short, cells were washed with ice-cold
phosphate-buffered saline (PBS) twice and collected in 1 ml PBS, and an
aliquot was used for measurement of protein. Two milliliters of
ice-cold 6% perchloric acid was added, and tubes were incubated on ice
for 10 min before centrifugation for 10 min at 14,000 g. The
supernatant was neutralized with a solution of 3 M potassium carbonate
and 0.5 M triethanolamine to pH 7-9 followed by centrifugation at 14,000 g for 10 min at 4°C. Five-hundred-microliter
samples were mixed with 1 ml of a solution containing 50 mM glycine,
1.2 mM
-nicotinamide adenine dinucleotide, and 2.5 U of sorbitol
dehydrogenase for 30 min at 25°C followed by measurement of the
optical density at 340 nm.
Cell surface biotinylation and isolation of plasma membrane. Previously described methods were employed without modification (28) except sulfo-NHS-SS-biotin was used. Briefly, cells on two or three 100-mm culture dishes were rinsed with ice-cold PBS followed by incubation on a shaking platform for 30 min with 1.5 ml biotinylation buffer containing sulfo-NHS-SS-biotin. After washing and lysis of cells, streptavidin-agarose beads were added, and the tubes were rotated for 30 min at 4°C. Pellets were washed, and proteins were eluted from the beads with Laemmli loading buffer devoid of 2-mercaptoethanol and bromphenol blue (for measurement of protein using a Bio-Rad kit); this was followed by SDS-PAGE and Western blot analysis.
SDS-PAGE and Western blotting. Whole cell lysates were prepared by scraping the cells into 100 µl of lysis buffer (150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.1 mM phenylmethylsulfonyl fluoride; pH 7.4). Lysates were cleared of nuclei by centrifugation at 14,000 g for 1 min. Protein samples were separated by 10% SDS-PAGE and transferred to nitrocellulose membrane. The membrane was blocked by 5% nonfat milk and incubated with rabbit anti-GLUT-1 IgG (Chemicon International) at 1:3,000 dilution in Tris-buffered saline-Tween 20 (TBST: 50 mM Tris, 150 mM NaCl, and 0.05% Tween 20, vol/vol). The secondary antibody was 1:10,000 dilution of horseradish peroxidase-conjugated anti-rabbit antibody diluted in TBST. Immunoreactive bands were visualized on the Kodak X-Omat film with Western blot luminol reagent (Santa Cruz) and quantified by densitometry.
Northern blot analysis.
Clone 9 cells were exposed to isotonic or hypertonic medium for various
times as indicated in different experiments. Cytoplasmic RNA was
isolated and fractionated as described previously (26). Blots were probed using rat GLUT-1 (26) or aldose
reductase cDNA (11) labeled with
[
-32P]dCTP. A 915-bp aldose reductase cDNA fragment
was prepared by RT-PCR of Clone 9 cell cytoplasmic RNA employing
upstream and downstream oligonucleotides with the following sequences:
5'-atggctagccatctggaactc and 5'-tcagacttctgcgtggaagg,
respectively (11). Membranes were probed at 68°C
overnight using Quick-Hyb and washed four times for 15 min each with a
solution containing 0.1% SDS and 1× standard saline citrate (SSC) at
58°C. The blots were autoradiographed using X-ray film or by
employing a Phosphorimager (Molecular Dynamics). Relative intensities
of the specific mRNA bands were normalized against the 28S rRNA band
measured by ethidium bromide staining of the membrane.
Statistical analysis. Results are expressed as means ± SE. Unpaired Student's t-test was used, and P < 0.05 was considered significant (29).
| |
RESULTS |
|---|
|
|
|---|
Effect of hyperosmolarity on GLUT-1-mediated glucose transport,
GLUT-1 protein and mRNA content, and cell surface GLUT-1 content.
Figure 1 shows the time course of the
effect of hyperosmolarity (produced by the addition of 300 mosmol/l
mannitol to the medium) on the rate of cytochalasin B (CB)-inhibitable
glucose transport in Clone 9 cells. In repeated experiments it was
found that the rate of CB-inhibitable 3-OMG uptake increased ~2.5
fold (P < 0.05) at 3 and 6 h after exposure to
hyperosmolarity, and thereafter the rate increased markedly, reaching
15- and 25-fold of control levels by 24 and 48 h, respectively.
|
|
|
|
|
|
Effect of hyperosmolarity on aldose reductase mRNA expression and
cell sorbitol content.
Aldose reductase, an enzyme that is induced in response to
hyperosmolarity, catalyzes the production of sorbitol from glucose. The
effect of hyperosmolarity on aldose reductase mRNA expression was hence
determined (Fig. 6). In accordance with
previous reports that the content of aldose reductase mRNA is enhanced
in these and other cells (10, 16), we found a significant
increase in aldose reductase mRNA (~2.5-fold) as early as 3 h
after exposure to hyperosmolarity. Higher degrees of stimulation were
evident at later time points.
|
|
Mechanism of induction of GLUT-1 mRNA in response to
hyperosmolarity.
The increase in the content of GLUT-1 mRNA can be mediated by increased
GLUT-1 gene transcription, decreased GLUT-1 mRNA degradation, or a
combination of both mechanisms. To dissect the effects of hyperosmolarity on GLUT-1 mRNA expression, the RNA synthesis inhibitor, actinomycin D, was employed to determine whether changes in the rate of
GLUT-1 mRNA degradation play a role in the observed induction of the
mRNA. Cells were pretreated with isotonic or hypertonic media for
24 h before addition of actinomycin D, and cytoplasmic RNA was
collected after 0, 2, 4, and 6 h of exposure to the inhibitor. (The time of addition of actinomycin D was varied to enable harvesting of the cells at the same time.) Preexposure of cells to hyperosmolarity increased the relative content of GLUT-1 mRNA by ~9-fold compared with cells incubated under isotonic conditions (Fig.
7, A and B). The
half-life of GLUT-1 mRNA incubated in isotonic medium was 2.2 ± 0.1 h (n = 3), which is comparable to previous
observations in these cells (26). In these studies, the
half-life of GLUT-1 mRNA from each of three experiments was plotted,
and the resulting half-lives were averaged. After 24 h of
incubation in hypertonic medium, the half-life of GLUT-1 mRNA increased
to 7.9 ± 1.8 h (n = 3; P < 0.05).
These results suggest that the increase in the content of GLUT-1 mRNA
in response to hyperosmolarity is mediated in part by an increase in
the stability of the mRNA.
|
85,
66, and
60 or to
11 (constructs
G-J) resulted in a marked decrease in the basal rate
of transcription.
|
104 bp was associated
with significant increases in luciferase activities after exposure to
hyperosmolarity. Constructs G and H exhibited some basal activity and responded significantly to hyperosmolarity. In
contrast, GLUT-1 promoter constructs I and J
(containing less of the promoter) showed a small amount of basal
expression but failed to show any increase in luciferase expression in
response to hypertonic medium. Cells transfected with pGL2-Basic
(devoid of GLUT-1 promoter) showed a small amount of luciferase
expression, which was not stimulated in response to exposure to
hyperosmolarity (data not shown).
| |
DISCUSSION |
|---|
|
|
|---|
The present study focused on the stimulation of glucose transport in response to exposure to hyperosmolar conditions and yielded new insights on the mechanisms underlying this response. Results showed that the stimulation of GLUT-1-mediated glucose transport is biphasic with the early phase (0-3 h) being mediated entirely by posttranslational mechanisms, while the late phase (12-48 h) is associated with a dramatic enhancement of GLUT-1 gene expression. We demonstrated that sorbitol levels increased in cells as early as 3 h and that the stimulation of glucose transport during the early phase is not associated with an increase in the content of GLUT-1 in the plasma membrane. We made the further novel observation that the increase in cellular content of GLUT-1 mRNA in response to hyperosmolarity is mediated by both increased transcription and decreased degradation of GLUT-1 mRNA. Finally, we localized the region of the GLUT-1 promoter necessary for its basal expression and for the positive transcriptional response to hyperosmolarity to a 44-bp segment in the proximal 5'-flanking region of the gene.
The chronic phase of the adaptive response to hyperosmolarity is characterized by enhanced expression of several genes encoding proteins that mediate the accumulation of organic osmolytes; the specific genes are those encoding betaine, myo-inositol and taurine transporters, and the enzyme aldose reductase (10, 12). The transporters serve to increase the intracellular concentration of organic osmolytes by facilitating their transport from the external medium, while, in contrast, aldose reductase functions to convert intracellular glucose to sorbitol. The expression of these genes has been shown to be stimulated at the transcriptional level, and osmotic response elements have been identified in their promoter regions (8, 9); posttranscriptional mechanisms have also been demonstrated in some instances (31). In addition to the above, tissues differ in their usage of organic osmolytes during the adaptive response. For example, the concentration of all of the above osmolytes is upregulated in kidney medullary cells in response to hyperosmolarity, while all except sorbitol are accumulated in the rat brain during adaptation to acute and chronic hypernatremia (5, 18).
The increase in the content of GLUT-1 mRNA in response to hyperosmolarity occurred after a significant delay period (>9 h). This finding suggests that the measured changes in rates of synthesis and degradation of the mRNA also occurred after a significant delay period. The reason for this delay is not known. It is possible, for example, that changes occurring during the acute phase of the response, such as alterations in cell volume, ionic composition, or actin skeleton (24), help initiate the subsequent responses. In this context, the induction of aldose reductase mRNA and increased cellular content of sorbitol (a product of glucose metabolism), which was observed as early as 3 h, occurred significantly before the increase in the abundance of GLUT-1 mRNA. It is hence possible that the enhanced synthesis of sorbitol plays an important role in the induction of GLUT-1 mRNA. This issue requires further study.
The region of GLUT-1 promoter necessary for the response to
hyperosmolarity was demarcated to a 44-bp region of the proximal promoter (from
104 to
60). Moreover, this 44-bp region does not
contain a classical osmotic response element nor is there such an
element present in the published 600-bp segment of the proximal GLUT-1
promoter (33). The lack of a previously described consensus osmotic response element raises the possibility that the
induction of the GLUT-1 gene may occur secondary to the induction of
one or more genes. It is alternatively possible that exposure to
hyperosmolarity results in a stimulation of the transcriptional protein
complex of the GLUT-1 gene. Such a mechanism would help explain why the
promoter region mediating the hyperosmolar response appears to
correspond to the region necessary for basal transcription. A similar
finding concerning basal and stimulated expression was recently
reported in the transcriptional response of the aldose reductase gene
to hyperosmolarity in Clone 9 cells (16). Finally, the
44-bp segment located within the proximal promoter region of the GLUT-1
gene mentioned above is highly GC rich (~75%) and contains a typical
Sp1 binding site (and other Sp1-like binding sites) that has been
reported to be of importance in the developmental regulation of the
GLUT-1 gene in neonatal rat heart (25). In addition, an
Sp1 binding site has also been implicated as being responsible for the
induction of serum- and glucocorticoid-inducible protein kinase under
hyperosmotic stress (4). Whether this transcription factor
plays an important role in the response to hyperosmolarity is not
known. Further studies are necessary to determine the molecular basis
of the stimulation of GLUT-1 gene transcription as well as the
posttranscriptional stabilization of GLUT-1 mRNA in response to hyperosmolarity.
The small but significant increase in glucose uptake in the early phase (0 to 3 h) cannot be attributed to altered GLUT-1 gene expression or to increased translation of GLUT-1 and hence represents posttranslational regulation of GLUT-1-mediated glucose transport. Moreover, we found no evidence of an increase in the content of GLUT-1 in the plasma membrane at this early time point, suggesting an activation rather than a translocation mechanism. Acute stimulation of glucose uptake in the presence of a constant amount of cell GLUT-1 has also been observed in response to other stimuli (such as inhibition of oxidative phosphorylation) that can be classified as cellular stress (34). Stimulation of p38 mitogen-activated protein kinase (MAPK) has been implicated in the acute glucose transport response to stress (2), and p38 activation has been implicated in the increase in GLUT-1 content in response to hyperosmolarity after 24 h of exposure (30). Whether the early phase of the response to hyperosmolarity involves the p38 MAPK pathway needs to be verified. In addition, hyperosmolarity has been recently reported to acutely stimulate AMP-activated protein kinase (AMPK) (13), and we have observed that stimulation of the kinase is associated with an increase in GLUT-1-mediated glucose transport through an activation mechanism (1). It remains to be determined, however, whether the stimulation of AMPK mediates the acute glucose transport response to hyperosmolarity. In addition, we did observe a small but significant increase in cell GLUT-1 protein content 6 h after exposure to hyperosmolarity, a time at which no increase in the content of GLUT-1 mRNA had yet occurred. This finding suggests that the observed induction of GLUT-1 at this time point could be in part mediated at the translational level, in support of the possibility that the regulation of GLUT-1 expression and function can be mediated at multiple levels.
Previous results have shown that the transcription of GLUT-1 gene is enhanced in response to hypoxia (or by exposure to cobalt chloride as a surrogate of hypoxia), to inhibition of oxidation phosphorylation by azide, to an ionophore-induced increase in the concentration of cytosolic calcium, and after transformation (15, 34). The response to these stimuli, in addition to the response to hyperosmolarity shown here, may represent a generalized response of the GLUT-1 gene to cellular stress. Comparison of the findings of the present study with previous results identifying regions of the GLUT-1 promoter necessary for stimulation by hypoxia and azide demonstrates that different regions of the promoter mediate each of these responses. Specifically, a 666-bp region some ~6 kbp upstream to the transcriptional start site mediates the transcriptional response of the promoter to azide, while a ~480-bp region located ~2,500 bp upstream of the start site (and which contains a hypoxia-response element) is necessary for the stimulation by hypoxia or cobalt chloride (3, 6). Still another element in the mentioned ~480-bp region partly mediates the response to transformation (22). Finally, results of the present study showed that the region mediating the response to hyperosmolarity is in close proximity to the transcriptional start site. These findings suggest that the regions of the GLUT-1 promoter that mediate the transcriptional response of the gene to each of the above stressful stimuli (azide, hypoxia, transformation, and hyperosmolarity) are markedly different. The results hence imply that the above stimuli do not share a common transcriptional stress response pathway, and that different trans-acting factors are likely involved in the induction of the GLUT-1 gene in response to each of these stimuli.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-45945.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: F. Ismail-Beigi, Clinical and Molecular Endocrinology, Case Western Reserve Univ., Cleveland, OH 44106-4951 (E-mail: fxi2{at}po.cwru.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 26 September 2000; accepted in final form 8 June 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abbud, W,
Habinowski S,
Zhang JZ,
Kendrew J,
Elkairi FS,
Kemp BE,
Witters LA,
and
Ismail-Beigi F.
Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut-1-mediated glucose transport.
Arch Biochem Biophys
380:
347-352,
2000[Web of Science][Medline].
2.
Barros, LF,
Young M,
Saklatvala J,
and
Baldwin SA.
Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38 (MAP kinase) activation and protein synthesis inhibition in mammalian cells.
J Physiol (Lond)
504:
517-525,
1997
3.
Behrooz, A,
and
Ismail-Beigi F.
Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.
J Biol Chem
272:
5555-5562,
1997
4.
Bell, LM,
Leong MLL,
Kim B,
Wang E,
Park J,
Hemmings BA,
and
Firestone GL.
Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (sgk) by a p38 MAPK-dependent pathway.
J Biol Chem
275:
25262-25272,
2000
5.
Bitoun, M,
and
Tappaz M.
Gene expression of taurine transport and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme.
Mol Brain Res
77:
10-18,
2000[Medline].
6.
Ebert, BL,
Firth JD,
and
Ratcliffee PJ.
Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences.
J Biol Chem
270:
29083-29089,
1995
7.
Elbrink, J,
and
Bihler I.
Membrane transport: its relation to cellular metabolic metabolic rates.
Science
188:
1177-1184,
1975
8.
Ferraris, JD,
Williams CK,
Jung KY,
Bedford JJ,
Martin BM,
Burg MB,
and
Garcia-Perez A.
ORE, a eukaryotic minimal essential osmotic response element: the aldose reductase gene in hyperosmotic stress.
J Biol Chem
271:
18318-18321,
1996
9.
Ferraris, JD,
Williams CK,
Ohtaka A,
and
Garcia-Perez A.
Functional consensus for mammalian osmotic response elements.
Am J Physiol Cell Physiol
276:
C667-C673,
1999
10.
Garcia-Perez, A,
and
Burg MB.
Renal medullary organic osmolytes.
Physiol Rev
71:
1081-1115,
1991
11.
Garcia-Perez, A,
Martin B,
Murphy HR,
Uchida S,
Murer H,
Cowley BD,
Handler JS, Jr,
and
Burg MB.
Molecular cloning of cDNA coding for kidney aldose reductase.
J Biol Chem
264:
16815-16821,
1989
12.
Handler, JS,
and
Kwon HM.
Regulation of the myo-inositol and betaine cotransporters by tonicity.
Kidney Int
49:
1682-1683,
1997.
13.
Hayashi, T,
Hirshman MF,
Fujii N,
Habinowski SA,
Witters LA,
and
Goodyear LJ.
Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism.
Diabetes
49:
527-531,
2000[Abstract].
14.
Hwang, DY,
and
Ismail-Beigi F.
Regulation of GLUT1 gene by hyperosmolarity (Abstract).
FASEB J
14:
A349,
2000.
15.
Ismail-Beigi, F.
Metabolic regulation of glucose transporter.
J Membr Biol
135:
1-10,
1993[Web of Science][Medline].
16.
Iwata, T,
Minucci S,
McGowan M,
and
Carper D.
Identification of a novel cis-element required for the constitutive activity and osmotic response of the rat aldose reductase.
J Biol Chem
272:
32500-32506,
1997
17.
Koseoglu, MH,
and
Ismail-Beigi F.
Mechanism of stimulation of glucose transport in response to inhibition of oxidative phosphorylation: analysis with myc-tagged GLUT1.
Mol Cell Biochem
194:
109-116,
1999[Web of Science][Medline].
18.
Lien, YHH,
Shapiro JI,
and
Chan L.
Effects of hypernatremia on organic osmoles.
J Clin Invest
85:
1427-1435,
1990.
19.
Malone, JI,
Leavengood H,
Peterson MJ,
O'Brien MM,
Page G,
and
Aldinger CE.
Red blood cell sorbitol as an indicator of polyol pathway activity: inhibition by sorbinil in insulin-dependent diabetic subjects.
Diabetes
33:
45-49,
1984[Abstract].
20.
Mercado, CL,
Loeb JN,
and
Ismail-Beigi F.
Enhanced glucose transport in response to inhibition of respiration in Clone 9 cells.
Am J Physiol Cell Physiol
257:
C19-C28,
1989
21.
Mueckler, M.
Facilitative glucose transporter.
Eur J Biochem
219:
713-725,
1994[Web of Science][Medline].
22.
Murakami, T,
Nishiyama T,
Shirotani T,
Shinohara Y,
Kan M,
Ishii K,
Kanai F,
Nakazuru S,
and
Ebina Y.
Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes.
J Biol Chem
267:
9300-9306,
1992
23.
Olson, AL,
and
Pessin JE.
Structure, function, and regulation of the mammalian facilitative glucose transporter gene family.
Annu Rev Nutr
16:
235-256,
1996[Web of Science][Medline].
24.
Rizoli, SB,
Rotstein OD,
Parodo J,
James Phillips M,
and
Kapus A.
Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling.
Am J Physiol Cell Physiol
279:
C619-C633,
2000
25.
Santalucía, T,
Boheler BK,
Brand NJ,
Sahye U,
Fandos C,
Vinals F,
Ferre J,
Testar X,
Palacin M,
and
Zorzano A.
Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle.
J Biol Chem
274:
17626-17634,
1999
26.
Shetty, M,
Ismail-Beigi N,
Loeb JN,
and
Ismail-Beigi F.
Induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation.
Am J Physiol Cell Physiol
265:
C1224-C1229,
1993
27.
Shetty, M,
Loeb JN,
and
Ismail-Beigi F.
Enhancement of glucose transport in response to inhibition of oxidative metabolism: pre- and posttranslational mechanisms.
Am J Physiol Cell Physiol
262:
C527-C532,
1992
28.
Shetty, M,
Loeb JN,
Vikstrom K,
and
Ismail-Beigi F.
Rapid activation of GLUT1 glucose transporter following inhibition of oxidative phosphorylation in Clone 9 cells.
J Biol Chem
268:
17225-17232,
1993
29.
Snedecor, GW,
and
Cochran WG.
Statistical Methods. Ames, IA: Iowa State Univ. Press, 1976.
30.
Taha, C,
Tsakiridis T,
McMall A,
and
Kilp A.
Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways.
Am J Physiol Endocrinol Metab
273:
E68-E76,
1997
31.
Tsukamoto, H,
Hamada Y,
Wu D,
Boado RJ,
and
Pardridge WM.
GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues.
Mol Brain Res
58:
170-177,
1998[Medline].
32.
Wertheimer, E,
Sasson S,
Cerasi E,
and
Ben-Neriah Y.
The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible protein.
Proc Natl Acad Sci USA
88:
2525-2529,
1991
33.
Williams, SA,
and
Birnbaum MJ.
The rat facilitated glucose transporter gene. Transformation and serum-stimulated transcription initiate from identical sites.
J Biol Chem
263:
19513-19518,
1988
34.
Zhang, JZ,
Behrooz A,
and
Ismail-Beigi F.
Regulation of glucose transporter by hypoxia.
Am J Kidney Dis
34:
189-202,
1999[Web of Science][Medline].
This article has been cited by other articles:
![]() |
M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva Cellular Response to Hyperosmotic Stresses Physiol Rev, October 1, 2007; 87(4): 1441 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Hwang and F. Ismail-Beigi Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1 Am J Physiol Cell Physiol, February 1, 2006; 290(2): C337 - C344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jing and F. Ismail-Beigi Role of 5'-AMP-activated protein kinase in stimulation of glucose transport in response to inhibition of oxidative phosphorylation Am J Physiol Cell Physiol, February 1, 2006; 290(2): C484 - C491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mayer, M. Hockel, A. Wree, and P. Vaupel Microregional Expression of Glucose Transporter-1 and Oxygenation Status: Lack of Correlation in Locally Advanced Cervical Cancers Clin. Cancer Res., April 1, 2005; 11(7): 2768 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kempson, V. Parikh, L. Xi, S. Chu, and M. H. Montrose Subcellular redistribution of the renal betaine transporter during hypertonic stress Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1091 - C1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Nellis, C. B. Doering, A. Kasinski, and D. J. Danner Insulin increases branched-chain alpha -ketoacid dehydrogenase kinase expression in Clone 9 rat cells Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E853 - E860. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |